← Back to Search

Behavioral Intervention

Pivotal Response Treatment Online (PRT-O) Course for Autism Spectrum Disorder (PRT-O Trial)

N/A
Waitlist Available
Led By Grace Gengoux, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* 2:0 to 5:11 years at the time of consent
* diagnosed with ASD (based on history, review of available medical records including diagnostic testing, e.g., Autism Diagnostic Observation Schedule) or suspicion of Autism Spectrum Disorder diagnosis, and confirmed with Autism Diagnostic Interview-Revised (ADI-R)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks and 12 weeks
Awards & highlights

Summary

This is a research study that will assess the effects of a Pivotal Response Treatment Online Training Course (PRT-O) for training parents of children with Autism Spectrum Disorder (ASD). The study will specifically investigate whether participants can learn to deliver PRT effectively following participation in the Online training.

Who is the study for?
This trial is for parents of children with Autism Spectrum Disorder (ASD). It aims to teach them how to deliver Pivotal Response Treatment (PRT) through an online course. Specific eligibility criteria are not provided, but typically participants would need reliable internet access and a commitment to complete the training.
What is being tested?
The study is testing the effectiveness of an Online Pivotal Response Treatment Training Course (PRT-O) designed for parents. The goal is to see if parents can learn and apply PRT methods effectively with their ASD-diagnosed children after taking this online course.
What are the potential side effects?
Since this intervention involves educational material rather than medication or medical procedures, traditional side effects are not applicable. However, participants may experience stress or frustration associated with learning new techniques and applying them in a home setting.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline on Child Functional Verbal Utterances as measures on the Home Video Observation (HVO)
Change from Baseline on Parent Fidelity of Pivotal Response Treatment Implementation as measured on the Home Video Observation (HVO)
Secondary study objectives
Change from Baseline on the Clinical Global Impression Scales (CGI)
Change from Baseline on the MacArthur-Bates Communication Scales (CDI)
Change from Baseline on the Vineland Adaptive Behavior Scales -3 (VABS-3) Communication Domain
Other study objectives
Change from Baseline on the Dimensional Assessment of Repetitive Behavior Scale (DARB)
Change from Baseline on the Neurobehavioral Evaluation (NET) Tool
Change from Baseline on the Parent Stress Index (PSI)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pivotal Response Treatment Online (PRT-O) CourseExperimental Treatment1 Intervention
The PRT-O Online Course (PRT-O) will consist of 10 online lessons completed asynchronously through the Stanford LearnMed Online CANVAS Platform. Parents are expected to view the 10 lessons over the course of a 12-week study period, complete worksheets, and to practice PRT at home.
Group II: Delayed Treatment Group (DTG)Active Control1 Intervention
No intervention.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,432 Previous Clinical Trials
17,465,287 Total Patients Enrolled
35 Trials studying Autism Spectrum Disorder
4,127 Patients Enrolled for Autism Spectrum Disorder
Grace Gengoux, PhDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
44 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
44 Patients Enrolled for Autism Spectrum Disorder
~29 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top